| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/03/2008 | WO2008039218A2 Inhibitors of bruton's tyrosine kinase |
| 04/03/2008 | WO2008039200A1 Methods and compositions for treating lymphoma and myeloma |
| 04/03/2008 | WO2008039188A1 Method of treating cancer comprising introduction of heat and delivery of liposome containing an active agent or thermo-activated drug, gene or virus to tissue |
| 04/03/2008 | WO2008039085A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 04/03/2008 | WO2008038955A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 04/03/2008 | WO2008038832A1 Therapeutic agent, detection method and detection kit for breast cancer and ovarian cancer |
| 04/03/2008 | WO2008038705A1 Glycation inhibitor |
| 04/03/2008 | WO2008038692A1 Diaryl ketimine derivative |
| 04/03/2008 | WO2008038587A1 Cd20-negatively converted b cell malignant lymphocyte cell line and utilization of the same |
| 04/03/2008 | WO2008038579A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 04/03/2008 | WO2008038031A1 An improved process for the preparation of temozolomide and analogs |
| 04/03/2008 | WO2008038018A1 Novel minor groove binders |
| 04/03/2008 | WO2008038011A1 Pyrimidine derivatives as aurora a and aurora b inhibitors |
| 04/03/2008 | WO2008038010A1 Pyrazine derivatives and their use in therapy |
| 04/03/2008 | WO2008037716A2 Pharmaceutical compositions comprising nilotinib or its salt |
| 04/03/2008 | WO2008037459A1 Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 04/03/2008 | WO2008037080A1 Methods and compositions for immune response modulation and uses thereof |
| 04/03/2008 | WO2008021338A3 Tricyclic oxazolidone derivatives useful as pr modulators |
| 04/03/2008 | WO2008019290A3 Human antibodies to erbb 2 |
| 04/03/2008 | WO2008018783A3 Porphyrin activation by different spectrum electromagnetical waves-new malignant tumour treatment possibilities |
| 04/03/2008 | WO2008017883A3 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 04/03/2008 | WO2008014291A3 Compounds and compositions as hedgehog signaling pathway modulators |
| 04/03/2008 | WO2008013807A3 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 04/03/2008 | WO2007146796A3 Antiproliferative compounds, compositions and methods of use |
| 04/03/2008 | WO2007146375A3 Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer |
| 04/03/2008 | WO2007131767A3 Novel actives against prostate carcinoma |
| 04/03/2008 | WO2007126799A3 Compositions and methods of use for antibodies of c-met |
| 04/03/2008 | WO2007115045A3 Diagnostics and treatments for tumors |
| 04/03/2008 | WO2007114851A8 Methods and compositions to induce cell death of invasive tumors |
| 04/03/2008 | WO2007067695A3 Dna methylation as a target for diagnosis and treatment of chronic lymphocytic leukemia (cll) |
| 04/03/2008 | WO2007057440A3 Improved methods of using phosphoantigen for the treatment of cancer |
| 04/03/2008 | WO2007015923A8 Benzimidazoles useful as inhibitors of protein kinases |
| 04/03/2008 | US20080081835 Use of Ltb4 Inhibitors for the Treatment of B-Cell Leukemias and Lymphomas |
| 04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081811 5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-[5-(4-methyl-1-piperazinyl)methyl-2-pyrazinyl]amino-1,3-thiazole; anticarcinogenic agent; G1 phase in cell cycle; great selectivity |
| 04/03/2008 | US20080081809 Novel Compounds |
| 04/03/2008 | US20080081808 N-{4-[4-(2-{3-[(dimethylamino)methyl]phenyl}-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl]phenyl}-N'-phenylurea; antitumor and anticarcinogenic agent; G2 and mitotic phases in cycling cells; solid tumor and hematological cancers |
| 04/03/2008 | US20080081803 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 04/03/2008 | US20080081801 8,13-bisvinyl-2-methyl aminocarbonylethyl-18-(3-(1-imidazolyl)propylamino)carbonyl ethyl-3,7,12,17 tetramethylporphyrin iron complex; albumin clathrate; decreases radiation resistance of hypoxic region of the tumor tissues; highly safe |
| 04/03/2008 | US20080081800 2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs |
| 04/03/2008 | US20080081799 2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs |
| 04/03/2008 | US20080081795 Suppression of nuclear factor-kappaB dependent processes using oligonucleotides |
| 04/03/2008 | US20080081793 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 04/03/2008 | US20080081792 Expression vector comprising therapeutic RNA sequences for use in treatment and prevention of infection, viral diseases and cell proliferative disorders, tumor or cancer; antisense agents; gene expression inhibition |
| 04/03/2008 | US20080081791 Methods of using combinations of siRNAs for treating a disease or a disorder, and for enhancing siRNA efficacy in RNAi |
| 04/03/2008 | US20080081786 Cytokine protein family |
| 04/03/2008 | US20080081078 Administering an enzyme inhibibitor to cause reduction in myosin light chain phosphorylation and to induce apoptosis in tumor cells; breast cancer, prostate cancer, lung carcinoma, renal cell carcinoma, glioma, melanoma, chemotherapy resistant tumors or metastatic tumors |
| 04/03/2008 | US20080081065 Materials and methods for inhibiting wip1 |
| 04/03/2008 | US20080081045 Combination Therapy for Cancer |
| 04/03/2008 | US20080081043 Nucleotide sequences coding natural killer cell ligand for use as tool in treatment cell proliferative disorders |
| 04/03/2008 | US20080081041 Method of Using IL6 Antagonists with Mitoxantrone for Prostate Cancer |
| 04/03/2008 | US20080081039 Inorganic Selenium For Treatment Of Cancer |
| 04/03/2008 | US20080081032 Using reovirus construct as therapeutic tool to decrease pain associated with treatment of cell proliferative disorders |
| 04/03/2008 | US20080081031 Using polyethylene glycol conjugated interleukin-10 as antitumor agent in treatment of cell proliferative disorders |
| 04/03/2008 | DE102004011720B4 Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie Radio Halogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 04/03/2008 | CA2847852A1 Inhibitors of bruton's tyrosine kinase |
| 04/03/2008 | CA2770486A1 Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
| 04/03/2008 | CA2700579A1 Cancer vaccines and vaccination methods |
| 04/03/2008 | CA2700436A1 Cancer vaccines and vaccination methods |
| 04/03/2008 | CA2667756A1 Blocking of gene expression in eukaryotic cells |
| 04/03/2008 | CA2664847A1 Novel minor groove binders |
| 04/03/2008 | CA2664744A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 04/03/2008 | CA2664740A1 Combination treatment of cd38-expressing tumors |
| 04/03/2008 | CA2664375A1 Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 04/03/2008 | CA2664358A1 Diarylketimine derivative |
| 04/03/2008 | CA2664052A1 An improved process for the preparation of temozolomide and analogs |
| 04/03/2008 | CA2663731A1 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 04/03/2008 | CA2663243A1 Junctional adhesion molecule-c (jam-c) binding compounds and methods of their use |
| 04/03/2008 | CA2662992A1 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 04/03/2008 | CA2662864A1 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 04/03/2008 | CA2662571A1 Pharmaceutical compositions |
| 04/03/2008 | CA2662309A1 Crystalline forms of valrubicin and processes for their preparation |
| 04/02/2008 | EP1905844A2 Application of mRNA for use as a therapeutic agent against tumours |
| 04/02/2008 | EP1905837A1 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/02/2008 | EP1905832A2 Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 04/02/2008 | EP1905773A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 04/02/2008 | EP1905762A1 Pyrazolone derivative |
| 04/02/2008 | EP1905457A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/02/2008 | EP1905449A2 Vaccines |
| 04/02/2008 | EP1905445A1 Tumor growth inhibitor |
| 04/02/2008 | EP1905439A1 Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
| 04/02/2008 | EP1905437A1 Treatment of pain using satraplatin |
| 04/02/2008 | EP1905304A2 Treatment of neoplasms with viruses |
| 04/02/2008 | EP1904530A2 Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 04/02/2008 | EP1904504A2 Inhibitors of vegf receptor and hgf receptor signaling |
| 04/02/2008 | EP1904503A1 1h-thieno[2,3-c]-pyrazole compounds useful as kinase inhibitors |
| 04/02/2008 | EP1904498A1 Fused heterocyclic derivatives and use thereof |
| 04/02/2008 | EP1904494A1 Imidazo[1,2-a]pyridine compounds as vegf-r2 inhibitors |
| 04/02/2008 | EP1904490A1 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl]phenyl) pyridine-3- sulphonamide |
| 04/02/2008 | EP1904485A2 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use |
| 04/02/2008 | EP1904478A1 Acid addition salts of n-ethyl-n'-[2-methoxy-4-(5-methyl-4-{[(1s)-1-pyridin-3-ylbutyl]amino}pyrimidin- 2-yl)phenyl]urea and uses thereof |
| 04/02/2008 | EP1904471A1 Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| 04/02/2008 | EP1904460A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 04/02/2008 | EP1904459A1 New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide |
| 04/02/2008 | EP1904457A2 Compositions and methods for inhibition of the jak pathway |
| 04/02/2008 | EP1904440A1 Sulindac derivatives for treatment of cancer |
| 04/02/2008 | EP1904436A1 Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors |